Dr Richard C Gould, MD | |
1114 W Madison Ave, Athens, TN 37303-4150 | |
(423) 745-1411 | |
Not Available |
Full Name | Dr Richard C Gould |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 1114 W Madison Ave, Athens, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780661710 | NPI | - | NPPES |
3331012 | Medicaid | TN | |
P00352996 | Other | TN | RR MEDICARE |
4129532 | Other | TN | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD34249 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard C Gould, MD Po Box 220, Athens, TN 37371-0220 Ph: (423) 424-3695 | Dr Richard C Gould, MD 1114 W Madison Ave, Athens, TN 37303-4150 Ph: (423) 745-1411 |
News Archive
Summer's here and the living isn't always so easy especially if youre in the hospital. Patients who are vulnerable to infection run a greater risk of contracting Legionnaires disease, a severe form of pneumonia, during warm, humid weather, according to a study published in the Journal of Infectious Diseases.
Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. A new study from the Norwegian Institute of Public Health suggests that long-term use of paracetamol during pregnancy may increase the risk of adverse effects on child development.
"Real-Time Care Experience Feedback Using QR Codes," a Penn State project that allows hospital patients to inform hospital personnel of their experiences - good or bad - in real time, is the winner of the 2012 REACH Developer Challenge, sponsored by AcademyHealth and part of the Health 2.0 Developer Challenge.
ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on ponatinib, its investigational pan-BCR-ABL inhibitor, showing potent inhibition of all four members of the fibroblast growth factor receptor (FGFR) family of tyrosine kinases that are abnormally expressed in multiple cancers. ARIAD scientists are presenting the data this morning at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida.
The Wall Street Journal reports that this cut-off will apply to the hundreds of thousands of people who started signing up for insurance on the federal health exchange but got held up during their last-minute shopping. Also in the news, the latest from California and Georgia in terms of deadlines and enrollment efforts.
› Verified 4 days ago